Globus Medical Inc.
GMED | NYSE
$80.19
+$2.14 (+2.74%)
Nov 2, 2026, 11:39 AM ET · Market open
Market Data
Market Cap $10.77B
Enterprise Value $10B
Beta 0.96
Average Volume 1.51M
Shares Outstanding (Diluted) 138.19M
Shares Change YoY 1.24%
Institutional Ownership 88.81%
Exchange NYSE
ISIN US3795772082
Price Performance
Price Change 1M 6.1%
Price Change 3M -1.6%
Price Change 6M -11.5%
Price Change YTD -8.2%
Price Change 1Y 31.0%
Price Change 3Y 70.7%
Price Change 5Y 2.5%
1M CAGR (ann.) 5.4%
1Y CAGR (ann.) 26.9%
5Y CAGR (ann.) -0.5%
All-Time CAGR 12.8%
Valuation
PE Ratio 20.06
Forward PE 14.10
PEG Ratio 0.38
Forward PEG 0.66
PS Ratio 3.33
Forward PS 3.10
PB Ratio 2.20
P/FCF Ratio 13.96
P/Adj. FCF Ratio 14.94
P/OCF Ratio 11.60
EV/Sales 3.18
EV/EBIT 15.03
EV/EBITDA 11.41
EV/FCF 13.32
Earnings Yield 5.0%
FCF Yield 7.2%
Adj. FCF Yield 6.7%
Financial Health
Net Cash $595.14M
Total Debt $111.19M
Cash & Short-Term Investments $595.14M
Total Assets $5.49B
Current Ratio 4.62
Quick Ratio 2.93
Debt / Equity Ratio 0.02
Debt / EBITDA 0.13
Debt / FCF 0.15
OCF / Debt 8.19
Interest Coverage 0.00
Altman Z-Score 10.48
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 68.5%
Operating Profit Margin 20.8%
EBITDA Margin 30.1%
Net Profit Margin 17.0%
FCF Margin 23.9%
Adj. FCF Margin 22.3%
SBC / Revenue 1.6%
SBC Impact (per share) -6.5%
Returns
Return on Assets 9.8%
Return on Equity 11.6%
Return on Invested Capital 10.5%
Return on Capital Employed 13.0%
Return on Tangible Assets 15.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 42.1%
Revenue CAGR 5Y 27.6%
Revenue CAGR 10Y 18.9%
EPS CAGR 3Y 24.6%
EPS CAGR 5Y 16.7%
EPS CAGR 10Y 12.2%
FCF CAGR 3Y 83.7%
FCF CAGR 5Y 29.9%
FCF CAGR 10Y 21.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 18.6%
Revenue Growth Next 3Y 6.9%
Earnings Date Nov 5, 2026
EPS Estimate (next Q) $1.20
EPS Growth Est (next Q) 1.7%
Revenue Est (next Q) $792.41M
Revenue Growth Est (next Q) 3.0%
Fair Value Estimates
Graham Number $55.53
Graham Upside -28.9%
Lynch Fair Value $64.81
Lynch Upside -17.0%
Price Target $95.13
Price Target Upside 21.9%
Cash Flow
Operating Cash Flow $910.39M
Free Cash Flow $750.59M
Adj. Free Cash Flow $701.63M
FCF Per Share $5.54
OCF Per Share $6.73
OCF/S Ratio 28.9%
Income Statement
Revenue $3.14B
Gross Profit $2.16B
Operating Income $652.69M
EBITDA $876.26M
Net Income $535.46M
EPS (Diluted) $3.89
Revenue / Employee $524.15K
Profit / Employee $89.24K
Employees 6,000
Add to Watchlist
Select watchlists to add or remove GMED